MX342443B - Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion. - Google Patents
Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion.Info
- Publication number
- MX342443B MX342443B MX2011010976A MX2011010976A MX342443B MX 342443 B MX342443 B MX 342443B MX 2011010976 A MX2011010976 A MX 2011010976A MX 2011010976 A MX2011010976 A MX 2011010976A MX 342443 B MX342443 B MX 342443B
- Authority
- MX
- Mexico
- Prior art keywords
- vaccines
- attenuation
- mycoplasma bovis
- attenuated
- bovis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/35—Mycoplasma
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17254309P | 2009-04-24 | 2009-04-24 | |
| PCT/US2010/032149 WO2010124154A1 (en) | 2009-04-24 | 2010-04-23 | Vaccines comprising attenuated mycoplasma bovis strains and method for the attenuation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2011010976A MX2011010976A (es) | 2011-11-18 |
| MX342443B true MX342443B (es) | 2016-09-29 |
Family
ID=42331013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011010976A MX342443B (es) | 2009-04-24 | 2010-04-23 | Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9339533B2 (enExample) |
| EP (1) | EP2421556B1 (enExample) |
| JP (1) | JP5793808B2 (enExample) |
| KR (1) | KR101880888B1 (enExample) |
| CN (1) | CN102458461B (enExample) |
| AR (1) | AR076413A1 (enExample) |
| AU (1) | AU2010238689B2 (enExample) |
| BR (1) | BRPI1013836B1 (enExample) |
| CA (1) | CA2758733C (enExample) |
| CL (1) | CL2011002639A1 (enExample) |
| CO (1) | CO6460761A2 (enExample) |
| DK (1) | DK2421556T3 (enExample) |
| ES (1) | ES2630209T3 (enExample) |
| HU (1) | HUE033618T2 (enExample) |
| MX (1) | MX342443B (enExample) |
| NZ (1) | NZ595914A (enExample) |
| PL (1) | PL2421556T3 (enExample) |
| SG (2) | SG175323A1 (enExample) |
| UY (1) | UY32570A (enExample) |
| WO (1) | WO2010124154A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110059437A1 (en) * | 2006-09-07 | 2011-03-10 | Boehringer Ingelheim Vetmedica, Inc. | Pcr-based genotyping |
| CL2008003202A1 (es) | 2007-10-29 | 2009-11-27 | Boehringer Ingelheim Vetmedica Inc | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. |
| SG10201506597RA (en) | 2008-10-31 | 2015-10-29 | Boehringer Ingelheim Vetmed | Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition |
| UY32570A (es) | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
| US8440203B2 (en) * | 2009-11-06 | 2013-05-14 | Intervet Inc. | Methods of immunizing pregnant heifers at three months of gestation |
| CN102294026A (zh) * | 2010-11-17 | 2011-12-28 | 赤峰博恩药业有限公司 | 奶牛链球菌乳房炎灭活疫苗及其制备方法 |
| US9175049B2 (en) | 2012-10-24 | 2015-11-03 | The United States Of America, As Represented By The Secretary Of Agriculture | Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and protect against infection |
| NZ721269A (en) * | 2013-12-18 | 2017-09-29 | Asahi Chemical Ind | Method for detecting streptococcus bacterium contained in milk |
| CN103800901B (zh) * | 2014-01-27 | 2015-12-09 | 内蒙古华希生物科技有限公司 | 链球菌以及将其灭活得到的奶牛乳房炎疫苗 |
| DK3334454T3 (da) * | 2015-08-14 | 2022-11-14 | Zoetis Services Llc | Mycoplasma-Bovis-sammensætninger |
| CN105441368B (zh) * | 2016-01-19 | 2019-01-01 | 福清市默克兽医院 | 一株牛支原体及其应用 |
| CN107815439A (zh) * | 2016-09-14 | 2018-03-20 | 华威特（江苏）生物制药有限公司 | 牛传染性鼻气管炎病毒jsm株及其应用 |
| CN107759674B (zh) * | 2017-09-26 | 2021-12-28 | 中国农业科学院哈尔滨兽医研究所 | 一种牛支原体免疫相关性蛋白、含有该蛋白的检测试剂盒及其在牛支原体抗体检测中的用途 |
| CN109022314B (zh) * | 2018-08-06 | 2021-08-13 | 北京华夏兴洋生物科技有限公司 | 一株牛支原体及其在疫苗研制中的应用 |
| CN109847060A (zh) * | 2019-04-19 | 2019-06-07 | 黑龙江八一农垦大学 | 牛多杀性巴氏杆菌病、溶血性曼氏杆菌病二联灭活疫苗及其制备方法 |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| CN111733094B (zh) * | 2020-05-29 | 2022-09-09 | 内蒙古民族大学 | 一种牛源蜡样芽孢杆菌及其应用 |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
| AR124849A1 (es) | 2021-02-11 | 2023-05-10 | Intervet Int Bv | Vacuna para mycoplasma bovis |
| CN115869392B (zh) * | 2022-12-12 | 2025-06-24 | 内蒙古华希生物科技有限公司 | 牛病毒性腹泻病毒、传染性鼻气管炎病毒、副流感病毒3型和支原体四联灭活疫苗 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0994944A1 (en) | 1997-07-10 | 2000-04-26 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated |
| EP0965639A1 (en) | 1998-06-05 | 1999-12-22 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| CA2390613A1 (en) | 1999-11-08 | 2001-05-17 | Biomune | Vaccines for mycoplasma bovis and methods of use |
| US6548069B2 (en) | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
| US20030147914A1 (en) | 2001-07-02 | 2003-08-07 | Pfizer Inc. | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| MXPA03011924A (es) | 2001-07-02 | 2004-03-26 | Pfizer Prod Inc | Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado. |
| BR0211563A (pt) | 2001-08-28 | 2004-07-13 | Pfizer Prod Inc | Modelo de infecção por mycoplasma bovis e métodos para administração de m. bovis e para indução de lesões pneumÈnicas do pulmão |
| US7217420B2 (en) * | 2002-07-13 | 2007-05-15 | The University Of Georgia Research Foundation, Inc. | Mycoplasma gallisepticum formulation |
| DE102004025452A1 (de) | 2004-05-19 | 2006-01-19 | Boehringer Ingelheim Vetmedica Gmbh | Vakzine enthaltend BVDV |
| US20070009545A1 (en) | 2005-07-07 | 2007-01-11 | Joachim Frey | Mycoplasma subunit vaccine |
| US20110059437A1 (en) | 2006-09-07 | 2011-03-10 | Boehringer Ingelheim Vetmedica, Inc. | Pcr-based genotyping |
| CN100419073C (zh) * | 2006-09-28 | 2008-09-17 | 中国兽医药品监察所 | 猪喘气病活疫苗及其生产方法 |
| CL2008002675A1 (es) * | 2007-09-11 | 2008-11-07 | Wyeth Corp | Bacteria de mycoplasma gallisepticum atenuada; composicion de vacuna que la comprende; método de vacunación; y método de identificación de clones de mycoplasma gallisepticum atenuados. |
| US20090068231A1 (en) * | 2007-09-11 | 2009-03-12 | Wyeth | Live attenuated mycoplasma strains |
| CL2008003202A1 (es) * | 2007-10-29 | 2009-11-27 | Boehringer Ingelheim Vetmedica Inc | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. |
| EP2320943B1 (en) | 2008-07-03 | 2016-02-17 | Iowa State University Research Foundation, Inc. | Cattle vaccines |
| SG10201506597RA (en) | 2008-10-31 | 2015-10-29 | Boehringer Ingelheim Vetmed | Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition |
| UY32570A (es) | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
-
2010
- 2010-04-22 UY UY0001032570A patent/UY32570A/es active IP Right Grant
- 2010-04-23 JP JP2012507405A patent/JP5793808B2/ja active Active
- 2010-04-23 WO PCT/US2010/032149 patent/WO2010124154A1/en not_active Ceased
- 2010-04-23 KR KR1020117024968A patent/KR101880888B1/ko active Active
- 2010-04-23 PL PL10717367T patent/PL2421556T3/pl unknown
- 2010-04-23 BR BRPI1013836A patent/BRPI1013836B1/pt active IP Right Grant
- 2010-04-23 NZ NZ595914A patent/NZ595914A/en unknown
- 2010-04-23 SG SG2011077617A patent/SG175323A1/en unknown
- 2010-04-23 ES ES10717367.6T patent/ES2630209T3/es active Active
- 2010-04-23 CA CA2758733A patent/CA2758733C/en active Active
- 2010-04-23 DK DK10717367.6T patent/DK2421556T3/en active
- 2010-04-23 SG SG10201401784WA patent/SG10201401784WA/en unknown
- 2010-04-23 CN CN201080028660.0A patent/CN102458461B/zh active Active
- 2010-04-23 MX MX2011010976A patent/MX342443B/es active IP Right Grant
- 2010-04-23 AR ARP100101382A patent/AR076413A1/es active IP Right Grant
- 2010-04-23 US US12/766,084 patent/US9339533B2/en active Active
- 2010-04-23 HU HUE10717367A patent/HUE033618T2/en unknown
- 2010-04-23 EP EP10717367.6A patent/EP2421556B1/en active Active
- 2010-04-23 AU AU2010238689A patent/AU2010238689B2/en active Active
-
2011
- 2011-10-21 CL CL2011002639A patent/CL2011002639A1/es unknown
- 2011-11-11 CO CO11154171A patent/CO6460761A2/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| NZ595914A (en) | 2014-09-26 |
| CN102458461A (zh) | 2012-05-16 |
| KR101880888B1 (ko) | 2018-07-23 |
| CN102458461B (zh) | 2017-03-08 |
| SG10201401784WA (en) | 2014-08-28 |
| EP2421556A1 (en) | 2012-02-29 |
| JP2012524548A (ja) | 2012-10-18 |
| MX2011010976A (es) | 2011-11-18 |
| BRPI1013836B1 (pt) | 2020-04-14 |
| JP5793808B2 (ja) | 2015-10-14 |
| CA2758733C (en) | 2019-12-24 |
| US9339533B2 (en) | 2016-05-17 |
| EP2421556B1 (en) | 2017-04-05 |
| WO2010124154A1 (en) | 2010-10-28 |
| CO6460761A2 (es) | 2012-06-15 |
| KR20120109992A (ko) | 2012-10-09 |
| SG175323A1 (en) | 2011-11-28 |
| UY32570A (es) | 2010-11-30 |
| CA2758733A1 (en) | 2010-10-28 |
| PL2421556T3 (pl) | 2017-09-29 |
| DK2421556T3 (en) | 2017-07-10 |
| AU2010238689A1 (en) | 2011-11-03 |
| ES2630209T3 (es) | 2017-08-18 |
| CL2011002639A1 (es) | 2012-07-20 |
| AR076413A1 (es) | 2011-06-08 |
| HUE033618T2 (en) | 2017-12-28 |
| US20100272759A1 (en) | 2010-10-28 |
| AU2010238689B2 (en) | 2017-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011010976A (es) | Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion. | |
| MX2010003719A (es) | Vacuna de mycoplasma bovis y metodos de uso de la misma. | |
| WO2014018596A3 (en) | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides | |
| MX2016014807A (es) | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. | |
| CL2011002852A1 (es) | Uso de bacterias del acido lactico probioticas por un tratamiento con calor para la preparacion de composiciones para prevenir o tratar inmunodeficiencias causadas por infecciones bacterianas, virales, fungicas y/o parasitarias. | |
| PH12018501221A1 (en) | Mixture of hmos | |
| BR112018068593A2 (pt) | composições tópicas não aquosas que compreendem uma salicilanilida halogenada | |
| AR106800A1 (es) | Composiciones que comprenden cepas bacterianas | |
| MX354047B (es) | Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori. | |
| NZ713621A (en) | Compounds and methods of treating infections | |
| PH12016501879B1 (en) | Immunological composition containing attenuated histophilus somni | |
| PH12014502855A1 (en) | Attenuated streptococcus suis vaccines and methods of making and use thereof | |
| UA98506C2 (en) | Attenuated mycoplasma gallisepticum strains | |
| MX2017016401A (es) | Composiciones inmunogenas. | |
| CO6361948A2 (es) | Uso de antigeno de mycoplasma bovis | |
| ZA202203363B (en) | Immunogenic compositions | |
| EP2538970A4 (en) | TREATMENT OR PREVENTION OF INFECTION | |
| WO2014167582A3 (en) | Vaccine composition for prophylaxis in ruminants | |
| CL2017001818A1 (es) | Bacteria de ácido láctico y su uso para el tratamiento de mastitis | |
| GB2515222A (en) | Use of flagellin as a vaccine | |
| MX2015005112A (es) | Composicion inmunogenica contra la aeromonas hydrophila. | |
| BR112015011944A8 (pt) | linhagem bacteriana atenuada estável, seus usos e método para sua geração, composição de vacina | |
| MX2016004961A (es) | Procedimientos y composiciones para el tratamiento de infecciones por s. equi. | |
| WO2014033625A3 (en) | Oral care | |
| WO2014006601A3 (en) | Nanoparticle compositions of antibacterial compounds and other uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |